Where Is the Strictness in Document Review for High-Risk Products? What Are the Frequently Raised Deficiencies?
Views:82
Time:2026-11-06 11:09:21


The biggest regulatory differences between Malaysia, Singapore and Thailand: for Class B and higher medical devices, Conformity Assessment Body (CAB) conformity assessment must be completed before submission to MDA. Malaysia is governed by the Medical Device Act 737, with the Medical Device Authority (MDA) as the regulatory authority. Applications are submitted electronically via the MeDC@St portal, and technical dossiers adopt the ASEAN Common Submission Dossier Template (CSDT). Core rule: CAB conformity assessment first, then MDA registration review. CAB assessment is a mandatory prerequisite for registration and cannot be skipped. Many enterprises misunderstand the positioning of CAB, resulting in project delays. This open class at Beijing CMEF breaks down the registration process for Class C/D high-risk medical devices in Malaysia, key points of CAB assessment, timeline planning and common pitfalls.



一、Complete Four-Step Registration Process



Risk classification: 4 classes (Class A/B/C/D). 

CAB assessment is mandatory for Class B and above. CAB Conformity Assessment: MDA-recognized CAB reviews the full CSDT dossier and issues a conformity assessment report. Submit registration application via the MeDC@St system with the CAB assessment conclusion attached. MDA conducts compliance review. 

Approval and certificate issuance. The certificate is valid for 5 years, followed by import and distribution.


Note: Deficiency letters raised during the CAB phase will directly delay registration submission. The full CAB cycle must be included in project scheduling, rather than only counting the MDA review timeline.


二、CAB (Conformity Assessment Body)



A CAB is an MDA-recognized conformity assessment body responsible for auditing the quality management system and full CSDT technical dossier of the product. 

Major bodies: SIRIM QAS, SGS Malaysia, BSI Malaysia, DQS, etc. 

Lookup channel: Check the CAB directory on the MDA official portal portal.mda.gov.my.


For MDA registration submission, only uploading the CAB certificate is not acceptable. The full assessment report, list of non-closed items, and closure evidence for corrections must be submitted together.
三、Key Documentation for Class C/D High-Risk Registration



Class C/D high-risk devices share the same CSDT template as Class B devices, but the evidence strength for review is significantly higher:
  • QMS: ISO 13485 certificate. The system scope must cover all declared products.
  • Declaration of Conformity (DoC): Mapped item by item against the Essential Principles (EP) checklist.
  • Clinical Evaluation Report (CER): Higher evidence requirements; literature alone is not sufficient.
  • Free Sale Certificate (FSC) / Overseas Approval Certificate: Must be legally authenticated, and the approved intended use shall be fully consistent with the declaration.
  • Traceability matrix: EP → Risk → Evidence document → Labelling & IFU → CAB report page number, with complete cross-reference mapping.
  • Language: Technical documents in English. Labelling and IFU are available in Bahasa Malaysia or English. Paper IFU is mandatory for home-use medical devices; electronic IFU is acceptable for professional devices, provided version control and risk analysis are performed.


四、Reference Registration Timeline (Including CAB Assessment)



Risk ClassOverall Reference TimelineRemarks
Class B6–9 monthsSequential CAB + MDA review
Class C9–12 monthsCAB scheduling heavily impacts the overall timeline
Class D12–18 monthsHigh-risk implantable products are recommended to reserve time up to the upper limit

Certificate validity: 5 years. Renewal is not a direct certificate replacement. CAB reassessment must be completed before expiry. It is recommended to initiate renewal projects 1 year in advance to avoid certificate lapse.


五、Post-Marketing Compliance Obligations After Approval



  • MDA registration number must be printed on labels.
  • Importers shall hold a GDPMD certificate + MDA establishment license, supported by Letter of Authorization (LOA) for import. LOA does not require MDA approval but is mandatory for importers.
  • Changes are categorized into minor changes, major changes and re-registration. Major changes can only be implemented after MDA approval.
  • Post-market surveillance obligations: PMS & PMCF plans and reports, adverse event reporting.


六、Frequently Encountered Deficiencies & Pitfalls



(一)Common Deficiencies at CAB Stage
  • The CAB assessment scope fails to cover all declared models, with insufficient justification for representative models.
  • Only CAB certificate is submitted, missing assessment report, non-closed item list and correction closure evidence.
  • Inconsistencies between CSDT, EP, risk report and labelling/IFU.
  • Incomplete test reports: biocompatibility, sterilization, shelf life, EMC, software testing.

(二)Common Deficiencies at MDA Registration Stage
  • Missing MDA registration number on labels; missing Bahasa Malaysia paper IFU for home-use devices.
  • Missing risk assessment and version control records for electronic IFU.
  • Insufficient clinical evaluation in CER, missing CV and conflict of interest statement of evaluators.
  • Missing PMS post-market surveillance plan / report.
七、Conclusion



Malaysia’s MDA operates under the ASEAN harmonized regulatory framework, with registration submissions via the MeDC@St system. It sets clear requirements for classification determination, local responsible parties and post-market traceability. Leveraging its mature mutual recognition system, proper dossier compliance and full-lifecycle control will not only facilitate smooth market access in Malaysia, but also serve as a key stepping stone for manufacturers to expand deeper into ASEAN and build multi-country compliance layouts.For further inquiries, please contact Wiselink.


Contact Us
Fill Form
Whether you need more information or wish to cooperate with us, we will guide you through every step of the regulatory process. Subscribe to our newsletter for the latest global regulatory updates.